Peter Libby Selected Research

Peter Libby Research Topics

Disease

167	Atherosclerosis 03/2024 - 01/2002
127	Inflammation (Inflammations) 03/2024 - 01/2002
77	Atherosclerotic Plaque (Atheroma) 03/2024 - 01/2002
63	Myocardial Infarction 05/2024 - 02/2002
61	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 09/2002
48	Thrombosis (Thrombus) 05/2024 - 05/2002
29	Coronary Artery Disease (Coronary Atherosclerosis) 04/2024 - 12/2002
23	Stroke (Strokes) 04/2024 - 05/2002
23	Acute Coronary Syndrome 01/2023 - 09/2003
21	Abdominal Aortic Aneurysm 01/2023 - 11/2004
15	Rupture 01/2023 - 10/2002
13	Obesity 09/2023 - 03/2006
13	Coronary Disease (Coronary Heart Disease) 01/2023 - 07/2004
12	Unstable Angina 10/2023 - 09/2003
11	Infections 09/2023 - 01/2002
11	COVID-19 09/2023 - 01/2020
10	Infarction (Infarctions) 01/2023 - 02/2002
10	Hypertension (High Blood Pressure) 09/2022 - 05/2002
10	Neoplasms (Cancer) 06/2022 - 11/2008
9	Heart Failure 11/2023 - 04/2014
9	Rheumatoid Arthritis 09/2022 - 04/2009
9	Fibrosis (Cirrhosis) 01/2022 - 03/2007
8	Type 2 Diabetes Mellitus (MODY) 11/2022 - 06/2003
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 02/2006
7	Insulin Resistance 09/2023 - 03/2004
7	Chronic Renal Insufficiency 01/2023 - 04/2009
7	Aneurysm (Aneurysms) 01/2022 - 05/2005
7	Dyslipidemias (Dyslipidemia) 10/2021 - 11/2004
7	Disease Progression 01/2018 - 04/2006
6	Atrial Fibrillation 02/2024 - 07/2011
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 09/2003
6	Osteoarthritis 09/2022 - 04/2009
6	Vascular Diseases (Vascular Disease) 11/2020 - 12/2002
6	Diabetes Mellitus 01/2020 - 05/2002
5	Pathologic Constriction (Stenosis) 01/2023 - 01/2003
5	Hypoxia (Hypoxemia) 10/2022 - 08/2011
5	Arthritis (Polyarthritis) 09/2022 - 09/2002
5	Calcinosis 01/2020 - 06/2013
4	Gout 03/2024 - 10/2018
4	Necrosis 10/2023 - 11/2021

Drug/Important Bio-Agent (IBA)

62	LipidsIBA 01/2024 - 01/2002
54	CytokinesIBA 12/2023 - 01/2002
50	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2023 - 09/2002
43	CholesterolIBA 04/2024 - 05/2002
35	C-Reactive ProteinIBA 11/2023 - 03/2002
33	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2005
27	Apolipoproteins E (ApoE)IBA 10/2022 - 02/2005
26	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2002
24	Interleukin-6 (Interleukin 6)IBA 09/2023 - 09/2003
23	oxidized low density lipoproteinIBA 01/2024 - 09/2002
21	LDL CholesterolIBA 01/2023 - 06/2003
20	canakinumab FDA Link 12/2023 - 10/2011
20	CollagenIBA 01/2023 - 02/2002
20	Atorvastatin (Lipitor)FDA Link 01/2020 - 09/2003
18	Rosuvastatin Calcium (Crestor)FDA Link 08/2017 - 03/2004
16	Matrix Metalloproteinases (MMPs)IBA 11/2022 - 01/2002
16	Lipoproteins (Lipoprotein)IBA 01/2022 - 08/2002
15	InterleukinsIBA 01/2022 - 01/2002
15	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 03/2003
15	CD40 Ligand (CD40L)IBA 11/2011 - 12/2002
14	InflammasomesIBA 02/2024 - 10/2014
14	HDL CholesterolIBA 11/2022 - 06/2003
14	ApolipoproteinsIBA 05/2016 - 02/2005
12	ChemokinesIBA 10/2023 - 01/2002
12	Triglycerides (Triacylglycerol)IBA 11/2022 - 06/2003
11	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 08/2007
11	EnzymesIBA 11/2023 - 07/2004
11	Angiotensin IIIBA 01/2022 - 03/2009
11	Thromboplastin (Tissue Factor)IBA 01/2021 - 07/2002
11	LDL Receptors (LDL Receptor)IBA 11/2020 - 01/2002
10	Monoclonal AntibodiesIBA 12/2023 - 12/2012
10	Cysteine Proteases (Cysteine Protease)IBA 01/2018 - 08/2004
9	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2023 - 11/2012
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 10/2002
9	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 11/2004
9	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2015 - 09/2002
8	omega-Chloroacetophenone (Mace)IBA 12/2023 - 11/2013
8	Interleukin-18 (Interleukin 18)IBA 12/2022 - 01/2002
8	ElastinIBA 05/2016 - 04/2003
8	AdiponectinIBA 02/2013 - 03/2006
7	InterferonsIBA 11/2023 - 01/2002
7	Naproxen (Naprosyn)FDA LinkGeneric 09/2022 - 04/2009
7	Celecoxib (Celebrex)FDA Link 09/2022 - 04/2009
7	Ibuprofen (Motrin)FDA LinkGeneric 09/2022 - 04/2009
7	Immunoglobulin E (IgE)IBA 01/2020 - 09/2011
7	CathepsinsIBA 09/2019 - 04/2007
7	Collagenases (Collagenase)FDA Link 06/2014 - 02/2002
6	Messenger RNA (mRNA)IBA 06/2015 - 05/2006
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2024 - 07/2010
5	Insulin (Novolin)FDA Link 12/2022 - 05/2002
5	Cathepsin LIBA 01/2020 - 02/2006
5	Cathepsin KIBA 01/2019 - 05/2007
5	CalciumIBA 01/2018 - 09/2007
5	cathepsin SIBA 04/2015 - 03/2003
5	Interferon-gamma (Interferon, gamma)IBA 08/2009 - 05/2005
4	HDL LipoproteinsIBA 04/2024 - 11/2014
4	Complement System Proteins (Complement)IBA 12/2023 - 08/2002

Therapy/Procedure

83	Therapeutics 05/2024 - 01/2002
6	Secondary Prevention 03/2024 - 05/2007
5	Stents 03/2024 - 06/2011